About the Sachs BioCapital USA Forum
Returning to New York in March 2018, Sachs Associates is pleased to announce the Sachs BioCapital USA Forum. Building on the success of Sachs Forums in Europe and the USA, we decided to combine the 2nd Neuroscience BioPartnering & Investment and the 5th Cancer BioPartnering & Investment forums and make one event - Sachs BioCapital USA Forum (BCUSA) that will take place on the 21st of March at the at the New York Academy of Sciences.
The BCUSA showcases biotechs with advanced therapeutics and brings them together with pharma partnering executives and institutional investors, bankers and advisers. The programme features panels on pharma-biotech dealmaking, advances in different therapeutics areas and a keynote and roundtable on investment. We anticipate up to 250 delegates and 25 company presentations (public and private) and an emerging company track. Our online One-2-One meeting system with dedicated meeting facilities will provide numerous networking opportunities and will make event even more transactional.
Plenary Panels Include:
Confirmed Keynotes Include:
Confirmed Speakers & Chairs Include:
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
Presenters at 2017 forums:
Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.
Raise your company’s profile directly with your potential clients. All of our sponsorship packages are tailor made to each client, allowing your organisation to gain the most out of attending our industry driven events.
To learn more about presenting or sponsorship opportunities, please contact:
Silvia Kar on + 44 (0)203 463 4890 or by email: Silvia.
Pharma Licensing Groups in 2018 include:
Investors & Analysts Attending:
203 Investment Partners LLC
A C Binder Corp.
Aegis Capital Corp.
Alpine Equity Advisors
BioSense Global LLC
Biotech Alliances International, Inc.
Bradley Woods & Co.
Brookline Capital Markets
Canaccord Genuity, Inc.
Crown Point Group
CTI Life Sciences
Double U Fund/ Kareg
Excellentia Global Partners
F.B. Asset management
Goodwin Procter LLP
JMP Securities, LLC
Landmark Angels, Inc.
Life Sciences Research International BV
Little Gem Life SciencesLocust Walk
Loop Capital Markets
Maxim Merchant Capital
MedPro Investors, LLC
Mid Atlantic Bio Angels
MRL Ventures Fund
Murdock Capital Partners
Click Here to View All